Neurosteroids ameliorate conditioned fear stress: An association with sigma1 receptors

Neuropsychopharmacology

Volumn 23, Issue 3, 2000, Pages 276-284

  Noda, Yukihiro ^a   Kamei, Hiroyuki ^a   Kamei, Yukie ^a,b   Nagai, Taku ^a,b   Nishida, Mikio ^b   Nabeshima, Toshitaka ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Conditioned fear stress; DHEAS; Neurosteroids; Sigma1 receptors

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; N ALLYLNORMETAZOCINE; NEUROSTEROID; OPIATE AGONIST; OPIATE ANTAGONIST; PRASTERONE SULFATE; PREGNENOLONE SULFATE; PROGESTERONE; SIGMA 1 OPIATE RECEPTOR; SIGMA 1 OPIATE RECEPTOR AGONIST; SIGMA 1 OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG MECHANISM; ELECTRIC SHOCK; ENVIRONMENTAL FACTOR; FEAR; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANIMALS; ANTIPSYCHOTIC AGENTS; CONDITIONING (PSYCHOLOGY); DEHYDROEPIANDROSTERONE SULFATE; ELECTROSHOCK; FEAR; MALE; MICE; PHENAZOCINE; PREGNENOLONE; RECEPTORS, SIGMA; STEROIDS; STRESS, PSYCHOLOGICAL;

EID: 0034284671     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00103-2     Document Type: Article

References (51)

1. Baulieu E.E. Steroid hormones in the brain. several mechanisms? Fuxe K., Gustafson J.A., Wettenberg L. Steroid Hormone Regulation of the Brain. 1981;3-14 Pergamon Press, Oxford.
2. Bergeron R., De Montigny C., Debonnel G. Potentiation of neuronal response induced by dehydroepiandrosterone and its suppression by progesterone. Effects mediated via sigma receptors J Neurosci. 16:1996;1193-1202.
3. A receptor Brain Res. 561:1991;157-161.
4. Bowlby M.R. Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol. 43:1993;813-819.
5. A receptors Eur J Pharmacol. 325:1997;1-7.
6. 3H](+)pentazocine-define σ recognition sites by phenytoin. Life Sci. 53:1993;41-48.
7. Fanselow M.S. Conditional and unconditional components of post-shock freezing. Pavlov J Biol Sci. 15:1980;177-182.
8. Freeman A.S., Bunney B.S. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol. 104:1984;287-293.
9. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci. 6:1986;1757-1770.
10. Herman J.P., Guillonneau D., Dantzer R., Scatton B., Semerdjian-Rouquier L., Le Moal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:1982;2207-2214.
11. Inoue T., Koyama T., Yamashita I. Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol Biochem Behav. 24:1993;115-119.
12. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav. 49:1994;911-920.
13. 2+ responses. Structure-activity studies J Pharmacol Exp Ther. 271:1994;677-682.
14. 2+ in cultured rat hippocampal neurons. Neurosci Lett. 141:1992;30-34.
15. Kamei H., Kameyama T., Nabeshima T. SKF-10,047 reverses stress-induced motor suppression. Interaction with dopaminergic system Eur J Pharmacol. 260:1994;39-46.
16. 1 sites. Eur J Pharmacol. 299:1996;21-28. a.
17. 1 sites. Eur J Pharmacol. 309:1996;149-158. b.
18. 1 receptors in amelioration of conditioned fear stress in rats. Association with mesolimbic dopaminergic systems Eur J Pharmacol. 319:1997;165-172.
19. Kameyama T., Nagasaka M. Effects of apomorphine and diazepam in a quickly learned conditioned suppression in rats. Pharmacol Biochem Behav. 17:1982;59-63.
20. Kameyama T., Nagasaka M. Effects of apomorphine and methamphetamine on a quickly learned conditioned-suppression response in rats. Neuropharmacology. 22:1983;813-817.
21. Katoh A., Nabeshima T., Kuno A., Wada M., Ukai R., Kameyama T. Changes in striatal dopamine release in stress-induced conditioned suppression of motility in rats. Behav Brain Res. 77:1996;219-221.
22. 3H]dextromethorphen and sigma ligands to guinea-pig brain. Itzhak Y. Sigma Receptors. 1994;243-262 Academic Press, San Diego, CA.
23. A receptor. Mechanism of action and physiological significance Prog Neurobiol. 38:1992;379-395.
24. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands. Prog Neuro-Psychopharmacol Biol Psychiatry. 21:1997;69-102.
25. 1 receptors. Behav Brain Res. 83:1997;159-164.
26. 2 sites. Br J Pharmacol. 127:1999;335-342.
27. 1 receptors in the mouse forebrain. J Neurosci Res. 46:1996;734-743.
28. 25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 83:1998;413-428.
29. 3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. J Pharmacol Exp Ther. 257:1991;547-554.
30. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA. 92:1995;3774-3778.
31. Nabeshima T., Katoh A., Hiramatsu M., Kameyama T. A role played by dopamine and opioid neuronal systems in stress-induced motor suppression (conditioned suppression of motility) in mice. Brain Res. 398:1986;354-360.
32. Nagasaka M., Kameyama T. Effect of diazepam, meprobamate, chlorpromazine and apomorphine on a quickly learned conditioned suppression in mice. J Pharmacobio-Dyn. 6:1983;523-526.
33. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
34. Patrick S.L., Walker J.M., Perkel J.M., Lockwood M., Patrick R.L. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands. Eur J Pharmacol. 231:1993;243-249.
35. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 13:1992;85-86.
36. Reddy D.S., Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 791:1998;108-116.
37. 1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test. NeuroReport. 9:1998;3069-3073.
38. Ross S.B. Heterogeneos binding of σ radioligands in the rat brain and liver. Possible relationship to subforms of cytochrome P-450 Pharmacol Toxicol. 68:1991;293-301.
39. Schwartz S., Ohl P., Zzhou G.Z. Steroid binding at σ-"opioid" receptors. Science. 246:1989;1635-1637.
40. Steinfels G.F., Tam S.W. Selective σ receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol. 163:1989;167-170.
41. Su T.P., London E.D., Jaffe J.H. Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems. Science. 240:1988;219-221.
42. Tsuda A., Tanaka M., Ida Y., Tsujimaru S., Ushijima I., Nagasaki N. Effects of preshock experience on enhancement of rat brain noradrenaline turnover induced by psychological stress. Pharmacol Biochem Behav. 24:1986;115-119.
43. 1) receptors. Brain Res. 799:1998;64-77.
44. Vallée M., Mayo W., Darnaudéry M., Corpéchot C., Young J., Koehl M., Le Moal M., Baulieu E.E., Robel P., Simon H. Neurosteroids. Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus Proc Natl Acad Sci USA. 94:1997;14865-14870.
45. Volonte M., Ceci A., Borsini F. Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (1)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat. An in vivo microdialysis study J Pharmacol Exp Ther. 275:1995;358-367.
46. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors. Biology and function Pharmacol Rev. 42:1990;355-402.
47. Wieland S., Lan N.C., Mirasedeghi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3 α -ol-20-one. Brain Res. 565:1991;263-268.
48. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 41:1997;311-318.
49. Wu F.S., Gibbs T.T., Farb D.H. A positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol. 40:1991;333-336.
50. Yamada K., Nabeshima T. Stress-induced behavioral responses and multiple opioid systems in the brain. Behav Brain Res. 67:1995;133-145.
51. Yamada M., Nishigami T., Nakasho K., Nishimoto Y., Miyaji H. Relationship between sigma-like site and progesterone-binding site of adult male rat liver microsomes. Hepatology. 30:1994;1271-1280.